With FDA delays, $2 million average claims, and growing risk in consumables, Robert Balogh says recall insurance is still stuck in limbo
Everyone expected the recall market to explode – and yet, it hasn’t.
Years of supply chain shocks, regulatory shifts, and rising brand risks led many to believe that recall insurance – especially for small and midsize manufacturers – was poised for a breakout. But Robert Balogh (pictured), executive vice president at Amwins, said the wave still hasn’t hit. “It really hasn’t yet,” he said. “That’s not to say it won’t, but i